Digital health startup Eko Health has received FDA clearance for its AI-enabled Eko Low Ejection Fraction Tool (ELEFT) that helps detect low ejection fraction, a sign of heart failure, in just 15 seconds during routine exams with an Eko stethoscope. This tool is added to Eko’s SENSORA Cardiac Early Detection Platform, which already has FDA-cleared algorithms for AFib and heart murmurs. Eko aims to make early heart disease detection more accessible, especially in underserved communities. The company has received significant funding and has developed other AI-enabled tools for detecting heart conditions, while similar companies like CardioSignal and Ultromics are also making strides in the tech-enabled heart health space.
Source link
Eko Health’s AI-enabled cardiac tool receives FDA clearance
